GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting

GLP-2 analog teduglutide significantly reduces need for parenteral nutrition and stool frequency in a real-life setting

Background: To evaluate the benefits of teduglutide in a real-life setting, we analyzed the data of 14 patients with short bowel syndrome treated with teduglutide. Additionally, we studied glucagon-like peptide 2 (GLP-2) receptor expression in samples of small intestinal and colonic tissue to provid...

Full description

Bibliographic Details
Main Authors: Marc Schoeler, Thomas Klag, Judith Wendler, Simon Bernhard, Michael Adolph, Andreas Kirschniak, Martin Goetz, Nisar Malek, Jan Wehkamp
Format: Article
Language:English
Published: SAGE Publishing 2018-08-01
Series:Therapeutic Advances in Gastroenterology
Online Access:https://doi.org/10.1177/1756284818793343

Internet

https://doi.org/10.1177/1756284818793343

Similar Items